World's Best Scientists 2026 revealed!
Eduardo López-Collazo

Eduardo López-Collazo

D-Index & Metrics

Immunology

D-Index
43
Citations
8162
World Ranking
4831
National Ranking
66

Eduardo López-Collazo publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Eduardo López-Collazo sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 160 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Eduardo López-Collazo D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Eduardo López-Collazo sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 43 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Eduardo López-Collazo is affiliated with Hospital Universitario La Paz in Spain and has an extensive research portfolio primarily in the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Their work covers significant subfields such as Immunology, Infectious Diseases, Oncology, Molecular Biology, and Neurology.

Their research topics include:

  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Immune Cell Function and Interaction
  • Long-Term Effects of COVID-19
  • Immune cells in cancer
  • Cancer Cells and Metastasis
  • Vaccine Coverage and Hesitancy

Frequent collaborators in their research efforts are José Avendaño-Ortíz, Roberto Lozano-Rodríguez, Carolina Cubillos-Zapata, Karla Montalbán-Hernández, and Carlos del Fresno.

Eduardo López-Collazo's publications have appeared predominantly in venues such as Frontiers in Immunology, Cancers, International Journal of Molecular Sciences, IBJ Plus, and bioRxiv (Cold Spring Harbor Laboratory).

Notable recent publications include:

  • Immune Response and COVID-19: A mirror image of Sepsis (2020), International Journal of Biological Sciences
  • Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19 (2021), Cell Reports
  • Tumor stem cells fuse with monocytes to form highly invasive tumor-hybrid cells (2020), OncoImmunology
  • The induction of natural competence adapts staphylococcal metabolism to infection (2022), Nature Communications
  • Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation (2022), Frontiers in Immunology

The research spans immunological mechanisms in infectious diseases and cancer biology, exploring immune responses, vaccination outcomes, tumor microenvironment interactions, and metabolic adaptations during infections.

Best Publications

  • Endotoxin tolerance: new mechanisms, molecules and clinical significance

    Subhra K. Biswas;Eduardo Lopez-Collazo

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Human Monocytes Undergo Functional Re-programming during Sepsis Mediated by Hypoxia-Inducible Factor-1α

    Irina N. Shalova;Jyue Yuan Lim;Manesh Chittezhath;Annelies S. Zinkernagel

  • Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients.

    Carlos del Fresno;Francisco García-Rio;Vanesa Gómez-Piña;Alessandra Soares-Schanoski

  • Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes.

    Vanesa Gómez-Piña;Alessandra Soares-Schanoski;Alexandro Rodríguez-Rojas;Carlos del Fresno

  • Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences.

    Eduardo López-Collazo;Carlos del Fresno

  • Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients ☆

    Pedro Escoll;Carlos del Fresno;Lourdes Garcı́a;Gema Vallés

  • WIP1 phosphatase is a negative regulator of NF-kappaB signalling.

    Joanne Chew;Subhra Biswas;Sathyavageeswaran Shreeram;Mahathir Humaidi

  • Tumor Cells Deactivate Human Monocytes by Up-Regulating IL-1 Receptor Associated Kinase-M Expression via CD44 and TLR4

    Carlos del Fresno;Karel Otero;Lourdes Gómez-García;Maria Carmen González-León

  • Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance.

    Subhra K. Biswas;Pradeep Bist;Manprit Kaur Dhillon;Tasneem Kajiji

  • Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity

    Juan Manuel Torres;Rubén Martinez-Barricarte;Sonia García-Gómez;Marina S. Mazariegos

  • Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: down-regulation of TREM-1 as putative underlying mechanism.

    Carlos del Fresno;Vanesa Gómez-Piña;Vanesa Lores;Alessandra Soares-Schanoski

  • Hypoxia-induced PD-L1/PD-1 crosstalk impairs T-cell function in sleep apnoea.

    Carolina Cubillos-Zapata;Jose Avendaño-Ortiz;Enrique Hernandez-Jimenez;Victor Toledano

  • p21 mediates macrophage reprogramming through regulation of p50-p50 NF-κB and IFN-β

    Gorjana Rackov;Enrique Hernández-Jiménez;Rahman Shokri;Lorena Carmona-Rodríguez

  • Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion.

    Masatoshi Eto;Hisanori Mayumi;Yukihiro Tomita;Yasunobu Yoshikai

  • Triggering of peritoneal macrophages with IFN-alpha/beta attenuates the expression of inducible nitric oxide synthase through a decrease in NF-kappaB activation.

    Eduardo López-Collazo;Sonsoles Hortelano;Armando Rojas;Lisardo Boscá

  • Immune Response and COVID-19: A mirror image of Sepsis.

    Eduardo López-Collazo;José Avendaño-Ortiz;Alejandro Martín-Quirós;Luis A Aguirre

  • Protective effect of cyclosporin A and FK506 from nitric oxide-dependent apoptosis in activated macrophages.

    Sonsoles Hortelano;Eduardo López-Collazo;Lisardo Boscá

  • Arabinoxylan rice bran (MGN-3/Biobran) enhances natural killer cell-mediated cytotoxicity against neuroblastoma in vitro and in vivo.

    Antonio Pérez-Martínez;Jaime Valentín;Lucía Fernández;Enrique Hernández-Jiménez

  • Inflammatory responses associated with acute coronary syndrome up-regulate IRAK-M and induce endotoxin tolerance in circulating monocytes.

    Carlos del Fresno;Llanos Soler-Rangel;Alessandra Soares-Schanoski;Vanesa Gómez-Piña

  • Biofilm vs. planktonic bacterial mode of growth: Which do human macrophages prefer?

    Enrique Hernández-Jiménez;Rosa del Campo;Victor Toledano;Maria Teresa Vallejo-Cremades

  • A new IRAK-M-mediated mechanism implicated in the anti-inflammatory effect of nicotine via α7 nicotinic receptors in human macrophages.

    Maria C. Maldifassi;Gema Atienza;Francisco Arnalich;Eduardo López-Collazo

  • Inflammatory cytokines and organ dysfunction associate with the aberrant DNA methylome of monocytes in sepsis.

    Clara Lorente-Sorolla;Antonio Garcia-Gomez;Francesc Català-Moll;Víctor Toledano

Frequent Co-Authors

Lisardo Boscá
Lisardo Boscá Autonomous University of Madrid
Subhra K. Biswas
Subhra K. Biswas Agency for Science, Technology and Research
Felipe García
Felipe García University of Barcelona
Jean-Laurent Casanova
Jean-Laurent Casanova The University of Texas Southwestern Medical Center
David Gozal
David Gozal Marshall University
Vinay Tergaonkar
Vinay Tergaonkar Agency for Science, Technology and Research
Masahiro Yamamoto
Masahiro Yamamoto Osaka University
Antonio Cuadrado
Antonio Cuadrado Autonomous University of Madrid
Rafael Cantón
Rafael Cantón Instituto Ramón y Cajal de Investigación Sanitaria

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open doors to diverse career opportunities in healthcare and research. If you are new to the field, consider programs like online adn programs for non nurses, which provide a solid foundation in nursing principles and are accessible for beginners. These programs often lead to roles closely aligned with immunological health and patient care.

Accelerated options, such as 12-month accelerated nursing programs, offer a fast-track route for students looking to advance quickly. These programs build essential nursing skills that complement immunology expertise, preparing graduates for high-demand healthcare roles.

For those seeking entry-level practical nursing qualifications, it's worth exploring lpn programs with easiest admission requirements. These programs provide hands-on experience, which is valuable for immunology-related clinical work.

Finally, nurse practitioners play a critical role in immunology-focused patient care. To pursue this path, consider nurse practitioner programs with easy admission, designed to accommodate varying backgrounds and career goals while emphasizing advanced clinical training.

Best Scientists Citing Eduardo López-Collazo

Trending Scientists

Recently Published Articles